Thursday, January 15, 2026

AWS Gets Korea’s Top Cloud Security Nod—Clears Path for Public Sector Use

AWS Korea receives Level 1 certification from KISA, enhancing public sector cloud security and digital transformation capabilities.

LG’s K-EXAONE: How This 2024 AI Model Outperforms Global Rivals

LG AI Research unveils 'K-EXAONE', joining the global competition for top-tier AI models.

Solar Panels and Efficiency Measures Cut Campus Emissions by 20% at Seoul City University

Installing solar panels on campuses can significantly reduce carbon emissions, as shown by research from Seoul City University.

Tag: Biotech

Unlocking Opportunities: Highlights from the 2026 J.P. Morgan Healthcare Conference in San Francisco

The 44th JP Morgan Healthcare Conference in San Francisco drew a large crowd of professionals in formal attire early in the morning.

Samsung Biologics Targets Japan’s $12.3 Billion CDMO Market: What You Need to Know

Samsung Biologics expands in Japan, targeting top pharma firms with new CMO brand 'ExellenS' and enhancing production capabilities.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

No More Lab Rats? FDA Shift Spurs AI Boom in Drug Development

AI is transforming drug discovery in pharma, especially after the FDA's shift away from animal testing, enhancing efficiency.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Top News

- Our Sponsors Ad -

Follow us